AAAAAA
Results:
1-21
|
Results: 21
Authors:
Cramer, JA
Citation: Ja. Cramer, Assessing the severity of seizures and epilepsy: which scales are valid?, CURR OP NEU, 14(2), 2001, pp. 225-229
Authors:
Diaz, E
Levine, HB
Sullivan, MC
Sernyak, MJ
Hawkins, KA
Cramer, JA
Woods, SW
Citation: E. Diaz et al., Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia, J PSYCH NEU, 26(4), 2001, pp. 325-329
Authors:
Cramer, JA
Ben Menachem, E
French, J
Citation: Ja. Cramer et al., Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation, EPILEPSY R, 47(1-2), 2001, pp. 17-25
Authors:
French, J
Edrich, P
Cramer, JA
Citation: J. French et al., A systematic review of the safety profile of levetiracetam: a new antiepileptic drug, EPILEPSY R, 47(1-2), 2001, pp. 77-90
Authors:
Walter, RE
Cramer, JA
Tse, FLS
Citation: Re. Walter et al., Comparison of manual protein precipitation (PPT) versus a new small volumePPT 96-well filter plate to decrease sample preparation time, J PHARM B, 25(2), 2001, pp. 331-337
Authors:
Krystal, JH
Cramer, JA
Krol, WF
Kirk, GF
Rosenheck, RA
Citation: Jh. Krystal et al., Naltrexone in the treatment of alcohol dependence., N ENG J MED, 345(24), 2001, pp. 1734-1739
Authors:
Cramer, JA
Silberstein, SD
Winner, P
Citation: Ja. Cramer et al., Development and validation of the Headache Needs Assessment (HANA) survey, HEADACHE, 41(4), 2001, pp. 402-409
Authors:
Cramer, JA
French, J
Citation: Ja. Cramer et J. French, Quantitative assessment of seizure severity for clinical trials: A review of approaches to seizure components, EPILEPSIA, 42(1), 2001, pp. 119-129
Authors:
Cramer, JA
Arrigo, C
Van Hammee, G
Bromfield, EB
Citation: Ja. Cramer et al., Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam, EPILEPSY R, 41(1), 2000, pp. 29-38
Authors:
Rigsby, MO
Rosen, MI
Beauvais, JE
Cramer, JA
Rainey, PM
O'Malley, SS
Dieckhaus, KD
Rounsaville, BJ
Citation: Mo. Rigsby et al., Cue-dose training with monetary reinforcement - Pilot study of an antiretroviral adherence intervention, J GEN INT M, 15(12), 2000, pp. 841-847
Authors:
Cramer, JA
Rosenheck, R
Xu, WC
Thomas, J
Henderson, W
Charney, DS
Citation: Ja. Cramer et al., Quality of life in schizophrenia: A comparison of instruments, SCHIZO BULL, 26(3), 2000, pp. 659-666
Authors:
Heimlich, TE
Westbrook, LE
Austin, JK
Cramer, JA
Devinsky, O
Citation: Te. Heimlich et al., Brief report: Adolescents' attitudes toward epilepsy: Further validation of the Child Attitude Toward Illness Scale (CATIS), J PED PSYCH, 25(5), 2000, pp. 339-345
Authors:
Cramer, JA
Arrigo, C
Van Hammee, G
Gauer, LJ
Cereghino, JJ
Citation: Ja. Cramer et al., Effect of levetiracetam on epilepsy-related quality of life, EPILEPSIA, 41(7), 2000, pp. 868-874
Authors:
Propper, DJ
Braybrooke, JP
Taylor, DJ
Lodi, R
Styles, P
Cramer, JA
Collins, WCJ
Levitt, NC
Talbot, DC
Ganesan, TS
Harris, AL
Citation: Dj. Propper et al., Phase I trial of the selective mitochondrial toxin MKT 077 in chemo-resistant solid tumours, ANN ONCOL, 10(8), 1999, pp. 923-927
Authors:
Cramer, JA
Citation: Ja. Cramer, Practical issues in medication compliance, TRANSPLAN P, 31(4A), 1999, pp. 7S-9S
Authors:
Cramer, JA
Citation: Ja. Cramer, Quality of life assessment in clinical practice, NEUROLOGY, 53(5), 1999, pp. S49-S52
Authors:
Maier, SE
Cramer, JA
West, JR
Sohrabji, F
Citation: Se. Maier et al., Alcohol exposure during the first two trimesters equivalent alters granulecell number and neurotrophin expression in the developing rat olfactory bulb, J NEUROBIOL, 41(3), 1999, pp. 414-423
Authors:
Cramer, JA
Rosenheck, R
Citation: Ja. Cramer et R. Rosenheck, Enhancing medication compliance for people with serious mental illness, J NERV MENT, 187(1), 1999, pp. 53-55
Authors:
Cramer, JA
Westbrook, LE
Devinsky, O
Perrine, K
Glassman, MB
Camfield, C
Citation: Ja. Cramer et al., Development of the quality of life in epilepsy inventory for adolescents: The QOLIE-AD-48, EPILEPSIA, 40(8), 1999, pp. 1114-1121
Authors:
Cramer, JA
Fisher, R
Ben-Menachem, E
French, J
Mattson, RH
Citation: Ja. Cramer et al., New antiepileptic drugs: Comparison of key clinical trials, EPILEPSIA, 40(5), 1999, pp. 590-600
Authors:
Cramer, JA
Citation: Ja. Cramer, Consequences of intermittent treatment for hypertension: The case for medication compliance and persistence, AM J M CARE, 4(11), 1998, pp. 1563-1568
Risultati:
1-21
|